CAS RN: 1505453-59-7
2-[8-Chloro-6-(4-chloro-phenyl)-1-Methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl]-acetaMide
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
≥99% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250506
5mg / 10mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1505453-59-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Shanghai
Inquiry
1505453-59-7 / 2-[(4S)-6-(4-chlorophenyl)-1-methyl-8-(1-methylpyrazol-4-yl)-4H-[1,2]oxazolo[5,4-d][2]benzazepin-4-yl]acetamide
Standard CAS: 1505453-59-7
Multi CAS: No
Basic Information
copy
CAS
1505453-59-7 copy
Multi CAS
No copy
Molecular Formula
C24H20ClN5O2 copy
Molecular Weight
445.900000 copy
Exact Mass
445.130553 copy
SMILES
CC1=NOC2=C1C3=C(C=C(C=C3)C4=CN(N=C4)C)C(=N[C@H]2CC(=O)N)C5=CC=C(C=C5)Cl copy
InChI
InChI=1S/C24H20ClN5O2/c1-13-22-18-8-5-15(16-11-27-30(2)12-16)9-19(18)23(14-3-6-17(25)7-4-14)28-20(10-21(26)31)24(22)32-29-13/h3-9,11-12,20H,10H2,1-2H3,(H2,26,31)/t20-/m0/s1 copy
InChIKey
QFLGNZXBWIQDLQ-FQEVSTJZSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
32 copy
Aromatic heavy atom count
22 copy
Fraction Csp3
0.17 copy
Rotatable bonds
4 copy
H-bond acceptors
6 copy
H-bond donors
1 copy
Molar refractivity
122.52 copy
TPSA
99.3 copy
LogP / Solubility
WLOGP
4.47 copy
MLOGP
3.96 copy
XLogP3
3 copy
Consensus LogP
3.81 copy
Log S (ESOL)
-5.67 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-6.44 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-6.75 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-2.27 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
4 copy